retatrutide patent eli lilly Reminder: Has Been Exploiting T1Ds Since 1922 How to Survive the GLP-1

Semaglutide, when used as a subcutaneous injection, has a half-life of 5-6 days

Future research should aim to unravel the precise molecular mechanisms underlying these weight-independent benefits, enabling the development of new therapies that harness these anti-inflammatory pathways and potentially bypass the limitations of current interventions

These medications may also help lower blood pressure, improve lipid disorders and fatty liver disease, slow diabetes-related neuropathy, and reduce the risk of heart and kidney disease

Y.HsuC.-C.et al (2024)

Do not stop GLP-1 medication without consulting your prescriber, as the underlying condition (diabetes or obesity) requires ongoing management